Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Originator

Acree, S.F.

2

Pfizer

420

Eli Lilly

237

Merck

216

GlaxoSmithKline

193

All Match

Any Match

Exclude Selected

Exclude Selected

Development Status

Possibly Marketed Outside US

2

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

2016

2

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Unknown

2

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

2

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

2

EPA CompTox

2

FDA UNII

2

MERCK INDEX

2

PUBCHEM

2

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

1

Salts, Hydrates, Esters, etc.

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 2 of 2 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

BENZENE

J64922108F

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2016

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Phenyl sodium is organometallic compound. It is used to carry exchange reactions to produce phenylmalonic acid.

PHENYLSODIUM

SNA8TW8V4T

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2016

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Phenyl sodium is organometallic compound. It is used to carry exchange reactions to produce phenylmalonic acid.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1